MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
GLSI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Greenwich LifeSciences (GLSI) Ownership - Who owns Greenwich LifeSciences?

Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
3992 Bluebonnet Drive
Phone
+1 832 819-3232
Employees
8
Web
https://www.greenwichlifesciences.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
348.61M
P/E Ratio
N/A
Total Cash
10.51M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
1.80
Dividend Yield
N/A
Total Cash/Share
0.72
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
GLSI
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for GLSI
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
3992 Bluebonnet Drive
Phone
+1 832 819-3232
Employees
8
Web
https://www.greenwichlifesciences.com